Grosgogeat Y - Search Results

1

Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia.

Montalescot G, Faraggi M, Drobinski G, Messian O, Evans J, Grosgogeat Y, Thomas D. Montalescot G, et al. Among authors: grosgogeat y. Circulation. 1992 Jul;86(1):47-55. doi: 10.1161/01.cir.86.1.47. Circulation. 1992. PMID: 1617789 Clinical Trial.

2

[Value of antimyosin monoclonal antibody scintigraphy in the diagnosis of acute myocardial infarction].

Amoyal P, Montalescot G, Ancri D, Artigou JY, Thomas D, Drobinski G, Grosgogeat Y. Amoyal P, et al. Among authors: grosgogeat y. Arch Mal Coeur Vaiss. 1992 Mar;85(3):359-61. Arch Mal Coeur Vaiss. 1992. PMID: 1575615 French.

3

Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris.

Montalescot G, Drobinski G, Maclouf J, Maillet F, Salloum J, Ankri A, Kazatchkine M, Eugène L, Thomas D, Grosgogeat Y. Montalescot G, et al. Among authors: grosgogeat y. Circulation. 1991 Nov;84(5):2054-62. doi: 10.1161/01.cir.84.5.2054. Circulation. 1991. PMID: 1934381

4

Coronary blood flow reserve measured by contrast media injection depends on myocardial viability.

Drobinski G, Montalescot G, Moussallem N, Canny M, Grosgogeat Y. Drobinski G, et al. Among authors: grosgogeat y. Eur Heart J. 1991 Jan;12(1):44-9. doi: 10.1093/oxfordjournals.eurheartj.a059823. Eur Heart J. 1991. PMID: 2009892

5

[Coronary restenosis: the cardiologist facing problems of definitions].

Charron P, Montalescot G, Drobinski G, Grosgogeat Y, Thomas D. Charron P, et al. Among authors: grosgogeat y. Arch Mal Coeur Vaiss. 1995 Jan;88(1):13-9. Arch Mal Coeur Vaiss. 1995. PMID: 7646244 French.

6

Fibrinogen after coronary angioplasty as a risk factor for restenosis.

Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thomas D. Montalescot G, et al. Among authors: grosgogeat y. Circulation. 1995 Jul 1;92(1):31-8. doi: 10.1161/01.cir.92.1.31. Circulation. 1995. PMID: 7788913

7

[Postinfarction hibernating myocardium].

Montalescot G, Faraggi M, Drobinski G, Le Guludec D, Grosgogeat Y, Thomas D. Montalescot G, et al. Among authors: grosgogeat y. Arch Mal Coeur Vaiss. 1994 Jan;87(1):79-84. Arch Mal Coeur Vaiss. 1994. PMID: 7811155 French.

8

[Indium III monoclonal antimyosin antibody scintigraphy for the detection of chronic myocardial infarction apart from the acute phase].

Adrie C, Montalescot G, Basset JY, Amoyal P, Drobinski G, Grosgogeat Y, Ancri D, Thomas D. Adrie C, et al. Among authors: grosgogeat y. Arch Mal Coeur Vaiss. 1995 Dec;88(12):1863-8. Arch Mal Coeur Vaiss. 1995. PMID: 8729367 Review. French.

9

Lack of platelet-activating factor release during reversible myocardial ischaemia.

Montalescot G, Maclouf J, Drobinski G, Mencia-Huerta JM, Ankri A, Grosgogeat Y, Thomas D. Montalescot G, et al. Among authors: grosgogeat y. Eur Heart J. 1992 Dec;13(12):1641-4. doi: 10.1093/oxfordjournals.eurheartj.a060118. Eur Heart J. 1992. PMID: 1289094

10

[Birth anomalies of coronary arteries. Responsibility in myocardial ischemia].

Salloum JA, Thomas D, Grosgogeat Y. Salloum JA, et al. Among authors: grosgogeat y. Presse Med. 1992 Jul 4-11;21(25):1172-4. Presse Med. 1992. PMID: 1409467 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters